Shares of Ardent Health, Inc. (“Ardent Health”) plummeted over 33% in intraday trading on November 13, 2025, after the company reported a $43 million decrease in revenue following recent “hindsight evaluations of historical collection trends,” along with a $54 million rise in its professional liability reserves. Gibbs Mura is investigating a potential Ardent Health, Inc. (NYSE: ARDT) Securities Class Action Lawsuit for investors over the company’s possible violations of federal securities laws.
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Ardent Health posted a strong Q3 earnings beat but slashed its full-year 2025 guidance, causing the stock to plummet over 25% as investors focused on future headwinds.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended September 30, 2025.
Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the 2025 Stephens Annual Investment Conference on Tuesday, Nov. 18, 2025, in Nashville, Tennessee.
Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its third quarter 2025 results after the market closes on Wednesday, November 12, 2025. A conference call will be held the following day, Thursday, November 13, 2025, at 9 a.m. ET to review the Company’s financial results and conduct a question-and-answer session.
Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it has successfully amended and extended its $777.5 million Term Loan Facility. The new terms reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 2.75% to Term SOFR plus 2.25%. The transaction extends the maturity of the facility to September 2032.
Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that members of the Company’s management team will participate in the following upcoming investor conferences:
